Michael Albert

Michael Albert, MD is the Editor-in-Chief of Substance Over Noise, a board-certified obesity medicine physician, clinical educator, and healthcare executive exploring the science, policy, and business of obesity, cardiometabolic health, and the future of medicine

Obesity Medicine Stopped Being a Horse Race

Nine drugs, four receptors, and two new pills into 2026, the field is quietly reorganizing around a better question. Not how much weight. Which disease.

Jul 4, 2026

•

11 min read

The Cancer We Vaccinated Away

For five straight years, not one young woman in England has died of cervical cancer. A new Lancet analysis shows what the end of a disease looks like in real time, and why the timing could not be more painful.

Jun 30, 2026

•

7 min read

The patient barely lost weight. He got better anyway.

What the newest trial data reveal about GLP-1 medicines, and why "weight loss drug" may be the least interesting thing about them.

Jun 27, 2026

•

10 min read

Medicare Will Pay for Wegovy Now. Here's the Catch.

Starting July 1, eligible Medicare patients get Wegovy, Zepbound, or the new pill Foundayo for $50 a month. The program is real. It's transformative. And almost everything you've read about it is slightly wrong.

Jun 23, 2026

•

8 min read

Obesity Care: I Was Wrong

I argued for fixing the system from the inside. The evidence changed my mind.

Jun 19, 2026

•

9 min read

Glucagon Doesn't Win the Scale. It Wins the Liver.

Survodutide and pemvidutide keep landing below 20% on body weight — while clearing liver fat at rates no pure GLP-1 can touch. A dispatch on the ADA 2026 readouts, and the case for grading incretins on the right organ.

Jun 16, 2026

•

9 min read

Zero Calcium. Doubled Plaque.

A new natural-history study watched atherosclerosis grow in untreated, low-risk adults over five years — and quietly made the strongest case I’ve seen in years for treating LDL early and aggressively.

Jun 13, 2026

•

7 min read

The Cholesterol You Were Born With

Lp(a) drives heart attacks, strokes, and aortic stenosis in one in five people. Statins don’t touch it. Diet doesn’t move it. After six decades of therapeutic silence, 2026 is the year the verdict finally arrives — and a single gene edit may make the problem history.

Jun 9, 2026

•

10 min read

GLP-1 Resistance Is Real. You Probably Don’t Have It.

A genetic study just caught true GLP-1 resistance in the act. Almost no one being called a “non-responder” fits the description.

Jun 6, 2026

•

7 min read

Your Cells Remember the Obesity. The Memory Lasts Years.

Six papers, four cell types, one verdict: weight loss restores the scale long before it restores the biology.

May 30, 2026

•

12 min read

The Accidental Hormone.

A century-long hunt for a phantom gut hormone, a peptide chemist written out of the story, and a venomous desert lizard. Here is where Ozempic actually comes from — and who actually found it.

May 23, 2026

•

9 min read

ECO 2026: The Maintenance Era Begins.

Istanbul gave us the answers we have been waiting for. Obesity is now being treated like every other chronic disease — and the data is on the right side of history.

May 19, 2026

•

13 min read

The One Thing. Move.

If I could ask every patient, every reader, every person I know to change just one thing about their daily life — this would be it.

May 16, 2026

•

7 min read

The Healthcare System Is Burning Down the Doctor-Patient Relationship

And physicians are being manipulated into helping build the machinery designed to replace them.

May 11, 2026

•

8 min read

I LEFT TRADITIONAL HEALTHCARE

And there's no going back.

May 9, 2026

•

3 min read

How Much Muscle Are GLP-1 Patients Actually Losing?

Two systematic reviews. One question. Different answers.

May 6, 2026

•

17 min read

Before or After? The GLP-1 and Surgery Sequencing Question

The science of sequencing GLP-1 therapy and bariatric surgery — and why the answer is more complicated than anyone wants to admit.

Apr 22, 2026

•

17 min read

Inside the Peptide Revolution — What the Science Actually Shows

The science underpinning the peptide revolution is genuinely extraordinary. The human trials are not. A physician goes deep on both.

Apr 18, 2026

•

24 min read

Statins Don't Cause What You Think They Cause. Except When They Do.

Muscle damage. Memory loss. Cancer. Diabetes. Four fears, one physician, and what the evidence actually shows.

Apr 15, 2026

•

16 min read

Statins Don't Lower LDL.Your Liver Does.

The receptor story that explains 40 years of cardiovascular outcomes data — and why the pleiotropic hypothesis was never the whole story.

Apr 11, 2026

•

12 min read

The Longevity Stack

Six interventions. One thesis about time. What I take every morning and why the evidence earned each one a place in the rotation.

Apr 8, 2026

•

14 min read

I'm 36. I'm a Physician. I Take a Statin Every Day.

Here's what the evidence actually says — and why I stopped waiting for symptoms before acting on it.

Apr 4, 2026

•

16 min read

The Cholesterol Wars Are Over. LDL Won.

New guidelines. New trials. The same conclusion. The deniers didn't get the memo.

Apr 1, 2026

•

17 min read

What Semaglutide Teaches Us About How GLP-1 Regulates Body Weight

It's not the injection site. It's not gut GLP-1. It's not thermogenesis. The pharmacokinetics of semaglutide across multiple trials offer a surprisingly clean window into how this molecule — and this biology — actually works.

Mar 27, 2026

•

15 min read

Cleared for Takeoff

The Definitive GLP-1 Travel Guide — TSA, Storage, Dosing, and Everything In Between

Mar 25, 2026

•

12 min read